Bio-Techne appears overvalued despite strong revenue growth, solid debt coverage, and looming U.S. healthcare funding cuts.

Economic uncertainty can lead to rash decisions that cause trouble for investors. The best course of action? Remain calm and consider these strategies to help protect your money.

The company’s CMO, Geoff Seeley, talks about the company’s marketing plan and how it tries to differentiate PayPal from Venmo ...